NO301472B1 - Nye 7-substituerte-9-substituert amino-6-demetyl-6-deoksytetracykliner, og preparater derav - Google Patents

Nye 7-substituerte-9-substituert amino-6-demetyl-6-deoksytetracykliner, og preparater derav Download PDF

Info

Publication number
NO301472B1
NO301472B1 NO923857A NO923857A NO301472B1 NO 301472 B1 NO301472 B1 NO 301472B1 NO 923857 A NO923857 A NO 923857A NO 923857 A NO923857 A NO 923857A NO 301472 B1 NO301472 B1 NO 301472B1
Authority
NO
Norway
Prior art keywords
amino
dimethylamino
dioxo
bis
tetrahydroxy
Prior art date
Application number
NO923857A
Other languages
English (en)
Norwegian (no)
Other versions
NO923857L (no
NO923857D0 (no
Inventor
Joseph J Hlavka
Phaik-Eng Sum
Yakov Gluzman
Ving J Lee
Adma A Ross
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25092264&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO301472(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO923857D0 publication Critical patent/NO923857D0/no
Publication of NO923857L publication Critical patent/NO923857L/no
Publication of NO301472B1 publication Critical patent/NO301472B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/40Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/461,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Moulding By Coating Moulds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
NO923857A 1991-10-04 1992-10-02 Nye 7-substituerte-9-substituert amino-6-demetyl-6-deoksytetracykliner, og preparater derav NO301472B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77157691A 1991-10-04 1991-10-04

Publications (3)

Publication Number Publication Date
NO923857D0 NO923857D0 (no) 1992-10-02
NO923857L NO923857L (no) 1993-04-05
NO301472B1 true NO301472B1 (no) 1997-11-03

Family

ID=25092264

Family Applications (3)

Application Number Title Priority Date Filing Date
NO923857A NO301472B1 (no) 1991-10-04 1992-10-02 Nye 7-substituerte-9-substituert amino-6-demetyl-6-deoksytetracykliner, og preparater derav
NO2006015C NO2006015I2 (no) 1991-10-04 2006-11-15 Tigecyklin.
NO2017037C NO2017037I2 (no) 1991-10-04 2017-08-01 Tygacil er et antibiotika inneholdende en tetracyklinforbindelse betegnet tigecyklin - Forlenget SPC

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO2006015C NO2006015I2 (no) 1991-10-04 2006-11-15 Tigecyklin.
NO2017037C NO2017037I2 (no) 1991-10-04 2017-08-01 Tygacil er et antibiotika inneholdende en tetracyklinforbindelse betegnet tigecyklin - Forlenget SPC

Country Status (28)

Country Link
EP (1) EP0536515B1 (de)
JP (1) JP3186863B2 (de)
KR (1) KR100269072B1 (de)
CN (1) CN1048240C (de)
AT (1) ATE211128T1 (de)
AU (1) AU654049B2 (de)
BR (1) BR1100853A (de)
CA (1) CA2079692C (de)
CL (1) CL2004001623A1 (de)
CZ (2) CZ284209B6 (de)
DE (4) DE122006000058I2 (de)
DK (1) DK0536515T3 (de)
ES (1) ES2168254T3 (de)
FI (1) FI114911B (de)
HK (1) HK1011348A1 (de)
HU (2) HU219973B (de)
IL (3) IL103320A (de)
LU (1) LU91279I2 (de)
MX (1) MX9205532A (de)
NL (1) NL300244I2 (de)
NO (3) NO301472B1 (de)
NZ (1) NZ244585A (de)
PL (4) PL176333B1 (de)
PT (1) PT536515E (de)
SG (1) SG52361A1 (de)
SK (2) SK284826B6 (de)
TW (1) TW275616B (de)
ZA (1) ZA927607B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420272A (en) * 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5284963A (en) * 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
US5328902A (en) * 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5834450A (en) * 1994-02-17 1998-11-10 Pfizer Inc. 9- (substituted amino) -alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
CN102336680A (zh) 1999-09-14 2012-02-01 塔夫茨大学信托人 用基于过渡金属的化学制备取代四环素的方法
US8106225B2 (en) 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
EA200201046A1 (ru) 2000-03-31 2003-04-24 Трастис Оф Тафтс Коллидж 7- или 9-замещенные соединения тетрациклина, способ их получения (варианты), фармацевтическая композиция, способ лечения состояния, чувствительного к действию тетрациклина, у млекопитающего и реакционноспособное промежуточное производное
AU2001259701A1 (en) * 2000-05-15 2001-11-26 Paratek Pharmaceuticals, Inc 7-substituted fused ring tetracycline compounds
MXPA03000055A (es) * 2000-07-07 2003-07-14 Tufts College Compuestos de monociclina sustituidos en posicion 9..
US7094806B2 (en) 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
AU2002250331A1 (en) 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
EP1241160A1 (de) 2001-03-13 2002-09-18 Glaxo Group Limited Tetracyclinderivate und ihre Verwendung als Antibiotica
EA201000388A1 (ru) 2001-03-13 2010-10-29 Пэрэтек Фамэсьютикэлс, Инк. Замещенные соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния субъекта
US7553828B2 (en) 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
JP2004529927A (ja) * 2001-04-24 2004-09-30 パラテック ファーマシューティカルズ, インク. マラリアの治療のための置換されたテトラサイクリン化合物
JP2004537544A (ja) 2001-07-13 2004-12-16 パラテック ファーマシューティカルズ インコーポレイテッド 標的治療活性を有するテトラサイクリン化合物
AU2002365120A1 (en) 2001-08-02 2003-07-15 Paratek Pharmaceuticals, Inc. Medicaments
AU2003235759A1 (en) 2002-01-08 2003-07-24 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
EA201000491A1 (ru) * 2002-03-08 2010-08-30 Паратек Фармасьютикалс, Инк. Аминометилзамещенные тетрациклиновые соединения
CN101863841A (zh) 2003-07-09 2010-10-20 帕拉特克药品公司 取代的四环素化合物
UA83266C2 (en) * 2003-12-08 2008-06-25 Уайет Oxazole derivatives of tetracyclines
CN103224474B (zh) * 2004-05-21 2016-08-03 哈佛大学校长及研究员协会 四环素及其类似物的合成
US7534766B2 (en) 2004-11-05 2009-05-19 Wyeth Glucuronide metabolites and epimers thereof of tigecycline
AR057649A1 (es) 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
KR20080041722A (ko) * 2005-08-31 2008-05-13 와이어쓰 글리실사이클린의 9-아미노카르보닐 치환된 유도체
EP2026776A2 (de) 2006-05-15 2009-02-25 Paratek Pharmaceuticals, Inc. Verfahren zur regelung der genexpression oder genprodukte mithilfe von substituierten tetracyclinverbindungen
AR069494A1 (es) 2007-11-29 2010-01-27 Actelion Pharmaceuticals Ltd Derivados de acidos fosfonicos
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
ITMI20080807A1 (it) 2008-05-05 2009-11-06 Antibioticos Spa Procedimento per la preparazione di tigeciclina in forma amorfa
TW202021946A (zh) 2008-05-23 2020-06-16 美商派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
PT2682387E (pt) * 2008-08-08 2016-02-03 Tetraphase Pharmaceuticals Inc Compostos de tetraciclina substituídos com c7-flúor
US9073829B2 (en) 2009-04-30 2015-07-07 President And Fellows Of Harvard College Synthesis of tetracyclines and intermediates thereto
WO2010129057A2 (en) 2009-05-08 2010-11-11 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
PL2470500T3 (pl) 2009-08-28 2018-03-30 Tetraphase Pharmaceuticals, Inc. Związki tetracyklinowe
KR101799304B1 (ko) 2010-05-12 2017-11-20 렘펙스 파머수티클스 인코퍼레이티드 테트라사이클린 조성물
WO2013013504A1 (zh) * 2011-07-26 2013-01-31 山东亨利医药科技有限责任公司 替加环素衍生物
PL2890673T3 (pl) 2012-08-31 2019-06-28 Tetraphase Pharmaceuticals, Inc. Związki tetracyklinowe
EP3068370A2 (de) 2013-11-12 2016-09-21 Galenicum Health S.L. Stabile pharmazeutische zusammensetzungen
JP7492335B2 (ja) 2016-10-19 2024-05-29 テトラフェース ファーマシューティカルズ,インコーポレイテッド エラバサイクリンの結晶形

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338963A (en) * 1960-10-28 1967-08-29 American Cyanamid Co Tetracycline compounds
US3579579A (en) * 1968-04-18 1971-05-18 American Cyanamid Co Substituted 7- and/or 9-amino-6-demethyl-6-deoxytetracyclines

Also Published As

Publication number Publication date
SG52361A1 (en) 1998-09-28
NZ244585A (en) 1995-07-26
SK298492A3 (en) 1995-03-08
SK280837B6 (sk) 2000-08-14
NO2017037I1 (no) 2017-08-01
NO2017037I2 (no) 2017-08-01
FI924454A (fi) 1993-04-05
IL119590A (en) 1999-03-12
SK284826B6 (sk) 2005-12-01
AU654049B2 (en) 1994-10-20
KR100269072B1 (ko) 2000-10-16
CA2079692A1 (en) 1993-04-05
MX9205532A (es) 1993-04-01
JPH05255219A (ja) 1993-10-05
BR1100853A (pt) 1999-12-07
DE122006000058I1 (de) 2007-01-18
AU2618392A (en) 1993-04-08
HU219973B (hu) 2001-10-28
TW275616B (de) 1996-05-11
PL296143A1 (en) 1993-05-31
IL119590A0 (en) 1997-02-18
FI114911B (fi) 2005-01-31
ZA927607B (en) 1993-04-13
CZ284159B6 (cs) 1998-08-12
FI924454A0 (fi) 1992-10-02
CN1048240C (zh) 2000-01-12
HU9203110D0 (en) 1992-12-28
NO923857L (no) 1993-04-05
CA2079692C (en) 2004-06-08
PL175957B1 (pl) 1999-03-31
EP0536515B1 (de) 2001-12-19
PL172282B1 (pl) 1997-08-29
CN1072172A (zh) 1993-05-19
HUT63145A (en) 1993-07-28
HK1011348A1 (en) 1999-07-09
NL300244I1 (nl) 2007-01-02
NO923857D0 (no) 1992-10-02
KR930007894A (ko) 1993-05-20
DK0536515T3 (da) 2002-04-08
NO2006015I2 (no) 2011-03-14
EP0536515A1 (de) 1993-04-14
CL2004001623A1 (es) 2005-06-03
PL173311B1 (pl) 1998-02-27
PT536515E (pt) 2002-05-31
CZ298492A3 (en) 1993-05-12
DE69232302T4 (de) 2003-02-13
SK114999A3 (en) 2000-07-11
ATE211128T1 (de) 2002-01-15
IL103320A0 (en) 1993-03-15
ES2168254T3 (es) 2002-06-16
LU91279I2 (fr) 2006-12-11
IL103320A (en) 1998-12-06
DE69232302D1 (de) 2002-01-31
NL300244I2 (nl) 2007-01-02
PL176333B1 (pl) 1999-05-31
DE122006000058I2 (de) 2007-09-13
JP3186863B2 (ja) 2001-07-11
HU211172A9 (en) 1995-11-28
CZ309397A3 (cs) 1998-09-16
CZ284209B6 (cs) 1998-09-16
DE69232302T2 (de) 2002-08-14
NO2006015I1 (no) 2006-11-27

Similar Documents

Publication Publication Date Title
NO301472B1 (no) Nye 7-substituerte-9-substituert amino-6-demetyl-6-deoksytetracykliner, og preparater derav
USRE40086E1 (en) Method for treating bacterial infection with novel 7-substituted-9-substituted amino 6-demethyl-6-deoxytetracyclines
EP0535346B1 (de) 9-Amino-7-substituierte-6-Desmethyl-6-Desoxytetracyclin
KR101014918B1 (ko) 아미노-메틸 치환된 테트라시클린 화합물
KR100309539B1 (ko) 신규한-7-(치환)-9-(치환글리실)아미도)-6-데메틸-6-데옥시테트라사이클린및그의중간체및그들의생산방법
US20130029943A1 (en) Methods of Preparing Substituted Tetracyclines with Transition Metal-Based Chemistries
IL119750A (en) 7-) Transformed (-8-) Transformed-9-) Amino-Transformed (-6-Demethyl-6-DioxytetracyclinesNew Intermediates
USRE40183E1 (en) 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
JP4848287B2 (ja) テトラサイクリンのオキサゾール誘導体
HU212267B (en) Process for preparing 9-nitro-7-(substituted)-6-demethyl-6-desoxytetracyclin derivatives

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: TIGECYKLIN; NAT. REG. NO/DATE: EU106336001/NO 20060524; FIRST REG. NO/DATE: BE , EU106336001 20060424

Spc suppl protection certif: 2006015

Filing date: 20061115

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: TIGECYKLIN; NAT. REG. NO/DATE: EU106336001/NO 20060524; FIRST REG. NO/DATE: BE , EU106336001 20060424

Spc suppl protection certif: 2006015

Filing date: 20061115

Extension date: 20171002

MK1K Patent expired
SPCE Application to extend a supplementary protection certificate (spc)

Free format text: PRODUCT NAME: TYGACIL ER ET ANTIBIOTIKA INNEHOLDENDE EN TETRACYKLINFORBINDELSE BETEGNET TIGECYKLIN; NAT. REG. NO/DATE: NO , EU106336001 20060524; FIRST REG. NO/DATE: BE , EU106336001 20060424

Spc suppl protection certif: 2017037

Filing date: 20170801

SPCX Expiry of an spc

Free format text: PRODUCT NAME: TIGECYKLIN; NAT. REG. NO/DATE: EU106336001/NO 20060524; FIRST REG. NO/DATE: EU106336001 20060424

Spc suppl protection certif: 2006015

Effective date: 20171002

SPCH Extension of a supplementary protection certificate (spc) granted

Free format text: PRODUCT NAME: TYGACIL ER ET ANTIBIOTIKA INNEHOLDENDE EN TETRACYKLINFORBINDELSE BETEGNET TIGECYKLIN; NAT. REG. NO/DATE: NO , EU106336001 20060524; FIRST REG. NO/DATE: BE , EU106336001 20060424

Spc suppl protection certif: 2017037

Filing date: 20170801

SPCX Expiry of an spc

Spc suppl protection certif: 2017037